多机构前瞻性同行评审对放射治疗中靶区与危及器官勾画的影响
该研究评估了前瞻性多学科每日勾画查房中间行评审对计划靶区(PTV)和危及器官(OAR)修改建议的影响,共回顾2013年9月至2017年3月间7645例病例。结果显示9.7%的处方被建议修改PTV或OAR,其中PTV扩展建议多于缩减,且头颈部及调强放疗计划建议率较高。作者认为前瞻性同行评审可能系统性导致更大的勾画体积,或影响多中心临床试验。
要点
- 7645例中750例(9.7%)被建议修改PTV或OAR。
- PTV修改建议534例(7.0%),扩展309例(57.9%)多于缩减115例(21.5%)。
- OAR修改建议216例(2.8%),扩展102例(47.2%)多于缩减23例(10.6%)。
核心结论
- 同行评审对约10%的病例提出了PTV或OAR修改建议。
- PTV扩展建议的频率是缩减建议的2.5倍以上,是OAR扩展建议的3倍以上。
- 这一总体趋势在治疗技术、部位和医生经验中均存在。
- 前瞻性同行评审可能系统性产生更大的体积,可能影响多中心临床试验。
研究设计与样本
- 多机构前瞻性同行评审研究,评估2013年9月至2017年3月间7645例病例。
- 同行评审组根据循证科室指令评估每例PTV和OAR的适当性。
- 纳入8名初级和7名高级放射肿瘤科医生。
- 将修改建议分类为扩展、缩减、两者或不确定,并按技术、部位和医生经验分析。
主要发现
- 7645例处方中750例(9.7%)被建议修改PTV或OAR。
- PTV修改建议534例(7.0%):扩展309例(57.9%)、缩减115例(21.5%)、两者15例(2.8%)、不确定95例(17.8%)。
- OAR修改建议216例(2.8%):扩展102例(47.2%)、缩减23例(10.6%)、两者2例(0.9%)、不确定89例(41.2%)。
- PTV扩展原因包括淋巴结覆盖增加和因运动导致的边缘不足;OAR扩展原因包括遗漏关键结构和按科室标准化范围不足。
- 头颈部占PTV建议最大比例(28.8%);调强放疗计划获得最多PTV和OAR建议(分别为66.8%和74.5%)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: Peer review is an essential component of quality assurance programs in radiation oncology. The purpose of this work was to assess whether peer reviewers recommend expansion or reduction of planning target volumes (PTVs) and organs at risk (OARs) in prospective multidisciplinary daily contour rounds. METHODS AND MATERIALS: The peer group evaluated the appropriateness of PTVs and OARs for each case according to evidence-based departmental directives. We reviewed 7645 cases that presented between September 2013 and March 2017. We isolated recommendations for PTV/OAR modification and classified each as expansion, reduction, both, or indeterminate. Recommendations were analyzed by technique, site, and physician experience. RESULTS: Eight junior and 7 senior radiation oncologists were included. PTV or OAR modifications were recommended for 750 of 7645 prescriptions (9.7%). The peer group recommended PTV modifications for 534 prescriptions (7.0%): There were 309 expansions (57.9%), 115 reductions (21.5%), 15 both (2.8%), and 95 indeterminate (17.8%). Reasons for PTV expansions included increased nodal coverage and inadequate margins as a result of motion. The peer group recommended OAR modifications for 216 prescriptions (2.8%): There were 102 expansions (47.2%), 23 reductions (10.6%), 2 both (0.9%), and 89 indeterminate (41.2%). Reasons for OAR expansions included missing critical structures and inadequate extent as per departmental standardization. Head and neck represented the largest percentage of PTV recommendations (28.8%). Intensity modulated radiation therapy plans received the most PTV and OAR recommendations (66.8% and 74.5%, respectively). The recommendation rate for senior and junior faculty was 43% and 28%, respectively. CONCLUSIONS: Peer review resulted in recommendations for PTV or OAR change for approximately 10% of cases. Expansions of PTV were recommended >2.5 times more often than reductions and >3 times more often than OAR expansions. This general trend was identified for treatment technique, site, and physician experience. Prospective peer review could yield systematically larger volumes, which could affect multicenter clinical trials.
引用
- Riegel AC, Vaccarelli M, Cox BW, et al. Impact of Multi-Institutional Prospective Peer Review on Target and Organ-at-Risk Delineation in Radiation Therapy. Pract Radiat Oncol. 2018. PMID: 30415075. doi:10.1016/j.prro.2018.10.016
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。